Application Nr Approved Date Route Status External Links
NDA019845 None Ophthalmic None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Betoptic S ® Ophthalmic Suspension 0.25% Is Indicated For The Treatment Of Elevated Intraocular Pressure (Iop) In Patients With Chronic Open-Angle Glaucoma Or Ocular Hypertension. Betoptic S Ophthalmic Suspension 0.25% Is A Beta-Adrenergic Receptor Inhibitor Indicated For The Treatment Of Elevated Intraocular Pressure (Iop) In Patients With Chronic Open-Angle Glaucoma Or Ocular Hypertension ( 1 ). Carton

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Betaxolol Hydrochloride BETAXOLOL HYDROCHLORIDE ZINC1530567

Comments